Banque Transatlantique SA reduced its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 17.1% in the fourth quarter, HoldingsChannel reports. The fund owned 94,857 shares of the semiconductor company’s stock after selling 19,519 shares during the quarter. Synopsys makes up 1.1% of Banque Transatlantique SA’s holdings, making the stock its 20th largest holding. Banque Transatlantique SA’s holdings in Synopsys were worth $44,871,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Synopsys during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd acquired a new position in Synopsys in the fourth quarter worth approximately $28,000. Atlas Capital Advisors Inc. acquired a new position in Synopsys in the fourth quarter worth approximately $32,000. Phillip James Consulting Co. bought a new position in shares of Synopsys in the fourth quarter valued at $36,000. Finally, Kemnay Advisory Services Inc. bought a new position in shares of Synopsys in the fourth quarter valued at $35,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms have recently weighed in on SNPS. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research note on Thursday, May 28th. Bank of America boosted their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Stifel Nicolaus upped their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. BNP Paribas Exane lifted their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys has a consensus rating of “Hold” and a consensus target price of $563.81.
Synopsys Trading Down 1.3%
Shares of NASDAQ SNPS opened at $455.51 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73. The business has a 50-day moving average price of $478.23 and a two-hundred day moving average price of $462.09. The firm has a market capitalization of $87.22 billion, a PE ratio of 105.44, a PEG ratio of 2.71 and a beta of 1.22.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
